Experts review the current indications for NOACs as well as research on use as venous thromboembolism (VTE) prophylaxis in patients with cancer, who are critically ill, and with peripheral artery disease
This study suggests that lowering SBP <145 mmHg before oral anticoagulation initiation may decrease risk for hemorrhagic stroke in patients with hypertension and atrial fibrillation.
In stroke patients, continuous quality improvement should involve minimizing delays in door-to-puncture and door-to-reperfusion time to minimize poor patient outcomes.
Intensive blood pressure lowering nonsignificantly reduces the risk for recurrence among patients with a history of stroke compared with a standard BP-lowering regimen.
